Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | SMARCA4 |
Variant | L1202Pfs*14 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | SMARCA4 L1202Pfs*14 indicates a shift in the reading frame starting at amino acid 1202 and terminating 14 residues downstream causing a premature truncation of the 1647 amino acid Smarca4 protein (UniProt.org). Due to the loss of the Bromo domain (UniProt.org), L1202Pfs*14 is predicted to lead to a loss of Smarca4 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
SMARCA4 mutant SMARCA4 inact mut SMARCA4 L1202Pfs*14 |
Transcript | NM_003072.3 |
gDNA | chr19:g.11033348delT |
cDNA | c.3605delT |
Protein | p.L1202Pfs*14 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_003072.3 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_024451658.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
NM_001128848.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_024451660.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_024451665.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
NM_001128849.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_006722846.2 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
NM_001128846.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
NM_001128844.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_006722845.2 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_024451659.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
NM_001128845.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_024451662.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_024451663.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_024451666.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_024451664.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_024451667.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_024451661.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
NM_001128847.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
XM_011528198.1 | chr19:g.11033348delT | c.3605delT | p.L1202Pfs*14 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|